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CF patients are often treated with proton pump inhibitors (PPIs) to reduce acidic gastro-esophageal reﬂux (GER) and bronchial aspiration of
duodeno-gastric contents is common in CF. We have previously demonstrated that gastric juice (GJ) from patients “on” PPI can induce interleukin-8
(IL-8) production by bronchial epithelial cells in culture. We hypothesized that such effect would be more pronounced in CF patients known to have
high inﬂammatory susceptibility.We aimed to evaluate the effect of GJ on IL-8 production by primary bronchial epithelial cells (PBEC), derived from a
CF patient and a healthy subject.
Methods: PBEC obtained from one donor (normal PBEC) and one receptor (CF-PBEC) for lung transplantation were stimulated with GJ from
patients “off” and “on” PPI. IL-8 levels were measured in the supernatant.
Results: GJ from patients “on” PPI provoked a signiﬁcant higher IL-8 production compared to GJ from patients “off” PPI, both in normal PBEC
[462 (200–1468) vs. 11 (4–28) pg/ml, p = 0.0001] as in CF-PBEC [1468 (841–2449) vs. 85 (26–131) pg/ml, p b 0.0001]. Exposure of the cells to
GJ “off” PPI and “on” PPI provoked signiﬁcantly higher IL-8 production in the CF-PBEC compared to the normal PBEC [“off” PPI 85 (26–131)
vs. 11 (4–28) pg/ml, p = 0.01; “on” PPI 1468 (841–2449) vs. 462 (200–1468) pg/ml, p = 0.01]. Filtration (0.20 μm) of the GJ “on” PPI, to
eliminate large particles and bacterial sub-products, resulted in a signiﬁcant decrease of IL-8 production.
Conclusion: Patients with CF, treated with PPIs, have GJ with high pH and high endotoxin levels. These patients often have GER and bronchial
aspiration. The aspirated material (GJ “on” PPI) has a signiﬁcantly enhanced inﬂammatory effect on CF bronchial epithelial cells in culture. As
chronic PPI treatment in CF may result in a paradoxically increased inﬂammatory effect in the airways, alternative anti-reﬂux therapies should be
considered in CF.
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Gastro-esophageal reflux (GER) is a physiologic phenomenon
occurring in healthy subjects, mostly after the meal period [1].
Gastro-esophageal reflux disease (GERD) is defined as the
occurrence of symptoms and/or mucosal lesions due to reflux of
gastric contents into the esophagus. Increased reflux is very
common in adult patients with cystic fibrosis (CF), with a
prevalence in the order of 80 to 90% [2–4]. Patients with CF are
often treated with proton pump inhibitors (PPIs) not only to
reduce acid reflux, but also to compensate for decreased
bicarbonate secretion and to facilitate pancreatic enzyme
supplementation. PPI treatment reduces both acidity as well
as volume of the gastric contents, however, it does not
eliminate the occurrence of reflux [5]. Consequently acid
suppression will not prevent aspiration of gastric components,
like food particles, bile acids, trypsin and other duodeno-gastric
components.
We have previously also shown that little over half of the CF
patients (56%) have detectable bile acids in sputum, which is
suggestive of a high prevalence of aspiration of duodeno-gastric
contents into the lungs [6]. It has been hypothesized that
aspiration of (duodeno)-gastric contents can lead to chemical
injury, which can provoke airway constriction and edema
followed by an inflammatory response. Several studies have
reported a link between reflux/aspiration and neutrophilic
inflammation in the lungs, probably mediated via interleukin-8
(IL-8), which is a potent activator for neutrophils. Carpagnano et
al. found evidence of neutrophilic inflammation in the airways in
patients with reflux [7]. A paper by Sacco et al. suggests an active
pathogenic role of IL-8 in the recruitment and activation of
neutrophils in the airways of children with GER and asthma-like
symptoms [8]. Since aspiration of duodeno-gastric contents was
linked to the development of bronchiolitis obliterans syndrome
after lung transplantation, several studies have been performed to
determine their exact relationship. A clear correlation was found
between bile acid levels and IL-8 concentrations and the number
of neutrophils in bronchoalveolar lavage fluid of lung transplant
patients, suggesting that bile acids are capable of inducing IL-8
expression [9,10]. Our group previously demonstrated that
concentrations of bile acids in sputum of CF patients correlate
with levels of neutrophil elastase, an inflammatory marker in the
lungs [6].
Exposure of bronchial cells to acid provokes a significant
inflammatory reaction [11]. Our group previously showed that
even gastric juice of patients taking acid suppressive therapy
could provoke a significant inflammatory reaction in human
bronchial epithelial cells through elevated IL-8 concentrations
[12]. Furthermore, the in vitro inflammatory response after
stimulation with gastric juice of patients “on” PPI therapy,
diluted at pH 7, was even higher compared to stimulation with
gastric juice of patients “off” PPI.
It has been suggested that CF patients are more susceptible to
lung inflammation. Compared to non-CF controls, CF children
showed greater inflammation in the lungs in response to similar
levels of pulmonary infection [13]. A study by Joseph et al.
showed higher levels of IL-8 in CF primary airway epithelial cellsafter stimulation with Pseudomonas aeruginosa compared to
non-CF cells [14].
We hypothesized that exposure of CF bronchial epithelial
cells in culture to human gastric juice from patients both “on” as
well as “off” PPI would result in a higher inflammatory response
compared to that produced by non-CF bronchial epithelial cells.
2. Methods
2.1. Gastric juice
Gastric juice was obtained from 22 consecutive patients
undergoing gastroscopy at the Endoscopy Unit of the University
Hospital Gasthuisberg (Leuven, Belgium). These patients were
referred for diagnostic gastroscopy for gastrointestinal symptoms,
such as heartburn, abdominal pain and weight loss or for follow-up
gastroscopy. Ten patients were not taking acid suppression therapy
(from now on referred to as ‘patients “off” PPI’) and 12 patients
were receiving PPI therapy (from now on referred to as ‘patients
“on” PPI’) at the time of the gastroscopy.
Gastric juice samples were analyzed for pH, concentration
of bile acids, and the presence of endotoxin. Total bile acids
were measured using a commercially available enzymatic assay
(Bioquant, San Diego, USA). The lowest level of detection was
0.2 μmol/L. Gastric juice was analyzed for the presence and
concentration of gram negative endotoxin, using a Limulus
Amebocyte Lysate assay (LAL-assay, Lonza, Switzerland).
2.2. Primary bronchial epithelial cells
Primary bronchial epithelial cells (PBEC) were obtained from
the explant lungs of 1 CF patient receptor for lung transplantation
(CF-PBEC, genotype F508del/F508del) and from 1 donor
(normal PBEC) in accordance with procedures approved by the
UZ Leuven Ethical Committee (S51577). Cells were isolated and
cultured in DMEM-F12, with extra L-glutamine (2 mM),
penicillin (100 U/ml), streptomycin (100 μg/ml), amphotericin
B (1.25 μg/ml) and fetal bovine serum (10%) (Invitrogen,
Merelbeke, Belgium). Cells were grown at 37 °C and 5% CO2
and used between passage 3 and 6 as previously described [15].
2.3. Study design
After reaching confluency, cells were washed with phos-
phate buffered saline (PBS) and incubated with serum-free
DMEM-F12 for 24 h. Both normal PBEC as CF-PBEC were
exposed for 24 h to: 1) a negative control solution which is
serum-free cell culture medium; 2) a positive control by means of
interleukin-17 (IL-17) (10 ng/ml, R&D Systems, Abingdon,
UK), and 3) the gastric juice of patients “off” PPI and “on” PPI.
Gastric juices were tested individually on the cells and they were
not pooled.
IL-17 and gastric juice were dissolved in serum-free DMEM-
F12 (pH = 7). Gastric juice was used in a 1/1000 dilution as
previously described [12]. By adding gastric juice to the medium,
the acidity of the medium is not modified. When performing the
Fig. 1. Exposure of PBEC to gastric juice from patients “on” PPI resulted in a
significantly higher IL-8 production compared to exposure of the cells to gastric
juice from patients “off” PPI, both in the normal PBEC as in the CF-PBEC
(n N 10) (data represented as median with IQR).
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“initial” pH.
2.4. Measurement of IL-8
IL-8 concentration in supernatant of the cells was measured
using a commercially available ELISA (Invitrogen SA,
Merelbeke, Belgium).
2.5. Statistical analysis
Data are presented as median (25th–75th percentile), unless
stated otherwise. Deviations from Gaussian distribution were
tested using the Kolmogorov–Smirnov test. Comparison
between groups was done using an unpaired t-test or the
nonparametric Mann–Whitney U test. Correlations were made
using Spearman's test. Statistical significance was considered
when p b 0.05.
3. Results
3.1. Gastric juice analysis
A total of 22 gastric juice samples were analyzed for the
study. There were no differences in age or gender between the
groups “off” and “on” PPI. We could not find a difference in
concentration of bile acids in the gastric juice of patients “off”
PPI compared to patients “on” PPI [38 (10–172) vs. 27 (9–192)
μmol/L, p = NS]. As expected, the initial pH of gastric juice
was significantly lower in the “off” PPI group compared to the
“on” PPI group [3.5 (2.8–4) vs. 7 (6.3–8), p b 0.0001].
Exposure of the PBEC for 24 h to the negative control
induced almost no IL-8 production, both in normal PBEC as in
CF-PBEC [3 (1–6) vs. 10 (3–27) pg/ml, p = 0.09]. When
exposing the cells to IL-17, the positive control, we found a very
high expression of IL-8, both in normal PBEC as well as in
CF-PBEC and the IL-8 levels were significantly higher in
CF-PBEC compared to normal PBEC [1601 (1181–2226) vs.
564 (275–716) pg/ml, p = 0.0005].
Exposure of the bronchial cells to gastric juice from patients
“off” PPI for 24 h resulted in a pronounced IL-8 production,
both in normal PBEC as in CF-PBEC, which was significantly
higher in the CF-PBEC as compared to the normal PBEC [85
(26–131) vs. 11 (4–28) pg/ml, p = 0.01] (Fig. 1).
Gastric juice from patients “on” PPI provoked a significantly
higher IL-8 release compared to stimulation of the cells to
gastric juice from patients “off” PPI, both in normal PBEC as in
CF-PBEC [normal PBEC 462 (200–1468) vs. 11 (4–28) pg/ml,
p = 0.0001; CF-PBEC 1468 (841–2449) vs. 85 (26–131) pg/ml,
p b 0.0001]. The IL-8 production induced by GJ from patients
“on” PPI was also significantly higher in CF-PBEC compared to
normal PBEC [1468 (841–2449) vs. 462 (200–1468) pg/ml,
p = 0.01] (Fig. 1).
Filtration of the gastric juice from patients “on” PPI through a
0.20 μm filter, to eliminate large particles and bacterial
sub-products, resulted in a significant decrease of IL-8 produc-
tion, both in normal PBEC as in CF-PBEC [normal PBEC 462(200–1468) vs. 23 (10–33) pg/ml, p = 0.006; CF-PBEC 1468
(841–2449) vs. 172 (123–233) pg/ml, p = 0.0001] (Fig. 2a and b).
Levels of endotoxin were significantly higher in gastric juice
from patients “on” PPI compared to patients “off” PPI [6.72
(6.55–7.16) vs. 1.74 (0.25–5.81) EU/ml, p = 0.0003]. We found
a positive correlation between endotoxin levels and the “original”
pH of the gastric juice (r = 0.75, p b 0.0001).
We also found a positive correlation between IL-8 levels and
the “original” pH of the gastric juice, both in normal PBEC
(r = 0.66, p = 0.001) as in CF-PBEC (r = 0.73, p b 0.0001)
(Fig. 3a and b).
There was no significant correlation between levels of bile
acids in the gastric juice and IL-8 concentration.4. Discussion
It has been previously demonstrated by our group and others
that increased GER, mostly acidic, is very common in adult
patients with CF, ranging from 80% till 90% [2–4]. Treatment
of reflux with PPIs eliminates the acidic component of reflux,
without affecting other non-acidic duodeno-gastric compo-
nents. We previously also showed that little over half of the CF
patients (56%) aspirate duodeno-gastric components into the
lungs [6]. Similar to reflux, treatment with PPIs does not
eliminate the risk of aspiration. A link between reflux and/or
aspiration and lung inflammation has been suggested in GERD
and in asthma patients, however, this has not been extensively
studied in CF patients [7,8].
Fig. 2. Exposure of the gastric juice from patients “on” PPI after filtration (on PPI FIL) leads to a significantly lower IL-8 production compared to exposure to the
gastric juice without filtration (on PPI), both in normal PBEC (p = 0.006) (a) as well as in CF-PBEC (p = 0.0001) (b) (data represented as median with IQR).
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gastric juice from patients “on” and “off” acid suppressive
therapy in CF and normal primary bronchial epithelial cells in
vitro. The main findings of our study were: i) exposure of PBEC
to gastric juice from patients “on” PPI provoked a significantly
higher IL-8 production in vitro, compared to exposure to gastric
juice from patients “off” PPI; ii) after exposure of the cells to
filtrated gastric juice from patients “on” PPI, levels of IL-8
dropped significantly, and iii) production of IL-8 was significantly
higher in CF cells compared to normal bronchial epithelial cells.
We previously showed the presence of bile acids in sputum
of little over half of the CF patients, confirming aspiration of
duodeno-gastric components into the airways [6]. It has been
suggested that micro-aspiration might play an important role in
the pathophysiology of reflux-related respiratory disorders,
probably in addition to other mechanisms like the esophago-
bronchial reflex pathway and bronchial hypersensitivity. There
are several protective mechanisms against aspiration, such as
esophageal clearance, which has been suggested to be altered in
the CF population, and reflex closure of the UES and/or vocal
cords [2,16,17]. In healthy subjects, gastric aspirate may beFig. 3. We found a positive correlation between IL-8 levels and the “original” pH of th
CF-PBEC (r = 0.73, p b 0.0001) (b).cleared very rapidly from the lungs. However, due to failure of
normal mucociliary clearance, this protective mechanism is
altered in CF patients [18].
Although treatment with PPIs reduces the acidity and volume
of the refluxate, it does not abolish reflux, moreover, there
appeared to be a shift from acid to non-acid reflux when using
PPIs [5]. Gastric acid plays an important role as a defense
mechanism against ingested pathogens. Treatment with acid
suppressive agents will increase the pH of the stomach and lead to
an insufficient elimination of ingested pathogens [19]. It has been
shown that patients receiving PPI treatment have bacterial
overgrowth and present with more unconjugated bile acids in
gastric juice compared to patients without PPI treatment [20]. It
has also been shown that intensive care unit patients often develop
ventilator-associated pneumonia because of a higher risk of
aspirating bacterial colonized gastric contents [21,22].
Aspiration of acidic gastric juice damages airway epithelial
cells, probably due to the toxicity of a low pH [12,23,24]. In
2005, Davidson et al. showed that gastric (non-acid) particles
can contribute to lung injury [25]. It has been suggested that
aspiration-induced inflammation of the lungs is mediated viae gastric juice (GJ), both in normal PBEC (r = 0.66, p = 0.001) (a), as well as in
704 A. Pauwels et al. / Journal of Cystic Fibrosis 12 (2013) 700–705IL-8, which is a potent chemo-attractant and activator of
neutrophils. In LTx patients, clear correlations between levels
of bile acids and IL-8 in BALF have been found [9,10]. Wu et
al. demonstrated that exposure of airway epithelial cells in vitro
to chenodeoxycholic acid, a major component of bile acids, is
capable to induce an increase in IL-8 production [26]. Pepsin
itself is inactive at pH 6.5, however, it remains stable to pH 8.0
and can be reactivated when pH is reduced. Johnston and
colleagues revealed that pepsin can be cytotoxic to laryngeal
epithelial cells even at pH 7 [27]. In our experiments, gastric
juice from patients “off” PPI, did not result in a large IL-8
release. However, because we dilute the gastric juice (1/1000),
the pH of the applied solution is not acidic anymore, similar to
what might occur in the airways upon micro-aspiration and
dilution by epithelial lining fluid. Having a low pH in the
stomach might prevent bacterial overgrowth which may explain
the lower levels of endotoxin in gastric contents.
Recently, our group demonstrated that gastric juice of patients
taking acid suppressive therapy was able to induce an IL-8
mediated inflammation in bronchial epithelial cells in vitro. In
this study, we confirmed that exposing bronchial epithelial cells
to gastric juice from patients “on” PPI induced high levels of IL-8
[12]. We were unable to find a correlation between bile acid
levels and IL-8 production. This might suggest that other
components in the gastric juice are more responsible for the
inflammatory effect on bronchial epithelial cells and that
presence of bile acids in sputum might only be a marker of
aspiration. However, in these experiments, we used a dilution of
1/1000 of the gastric juice, so in fact, concentrations of bile acids
that reach the cells are really low. Secondly, buffering of the
gastric juice leads to a higher, more neutral pH, at which bile
acids might be less potent, which also might explain the lack of
pro-inflammatory effects induced by bile acids.
Several studies proposed the hypothesis that CF lungs are
more susceptible for inflammation compared to healthy lungs.
Khan et al. and Rosenfeld et al. have revealed elevated levels of
different cytokines and neutrophils in the lungs of CF patients,
even in those who have only mild lung disease or in the
absence of infection [28,29]. Muhlebach et al. found higher
levels of inflammatory cytokines in response to similar levels
of pulmonary infection in CF children compared to non-CF
controls and after stimulation of both CF and healthy airway
epithelial cells with P. aeruginosa, levels of IL-8 were found to
be significantly higher in the CF cells compared to the healthy
cells [13,14]. In this study, we could confirm these findings
and found that CF-PBEC secreted significantly higher levels of
IL-8 compared to H-PBEC, in all stimulation conditions.
The response to the filtered gastric juice “on” PPI was
significantly reduced, but still slightly higher compared to the
gastric juice “off” PPI. This suggests that bacterial sub-products or
endotoxin are very important in the inflammatory reaction, but not
the sole harmful agent in the gastric juice. Other (duodeno)-gastric
components active in a non-acid environment are probably
involved in the IL-8 mediated inflammatory response.
A weak point in our study was the use of primary cells from
only one CF patient and one healthy subject and more extensive
studies are needed to confirm these data. Although our in vitrostudy cannot be directly translated into clinical decision
making, based on our results, we can hypothesize that patients
with CF, treated with PPI, have a gastric juice with high pH and
high endotoxin levels due to bacterial contamination and
overgrowth. These patients often have reflux and bronchial
aspiration. The aspirated material (gastric juice “on” PPI) has a
significantly enhanced inflammatory effect on CF bronchial
epithelial cells in culture. As chronic PPI treatment in CF does
not prevent aspiration of gastric juice and may result in a
paradoxically increased inflammatory effect in the airways,
alternative anti-reflux therapies should be considered in CF
patients with increased GER and demonstrated aspiration.
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